Progressive Neurodegenerative Brain Disease in Dogs (Neuroaxonal Dystrophy)
- Occurrence: very rare
- Location of disease: Head/Neck
When to visit the vet?
Non-urgent see a veterinarian within 2–3 days
If the condition worsens / symptoms persist, consult a veterinarian.
Definition
Neuroaxonal dystrophy (NAD) in dogs is a genetic neurological disorder characterized by degenerative changes in the nerve cells of the brain and spinal cord. This disease leads to a progressive deterioration of motor functions and can cause severe neurological symptoms.
Das Wichtigste auf einen Blick
Neuroaxonal dystrophy in dogs is a genetic neurological disorder caused by the accumulation of abnormal proteins and lipids in the axons of nerve cells. These accumulations lead to damage and degeneration of the nerve cells, which impairs neurological functions. The disease is inherited in an autosomal recessive manner, meaning a dog needs two copies of the defective gene to be affected. Certain dog breeds such as Rottweilers, Chihuahuas, and Collies are particularly susceptible. Common symptoms include an uncoordinated gait, head tremors, and weakness. Diagnosis is based on clinical symptoms, genetic tests, and histopathological examinations. There is no cure; therefore, treatment focuses on alleviating symptoms, for example through physiotherapy and medication. The overall prognosis is unfavorable as the disease progresses and leads to severe disabilities. Prevention is possible through responsible breeding practices, where genetic tests help identify carriers of the defective gene and thus reduce its spread. Research focuses on genetic causes and the development of therapies that could slow the effects of the disease.
Ursachen
Neuroaxonal dystrophy is a condition associated with an abnormal accumulation of spheroid bodies in the axons of nerve cells. These spheroid structures result from the accumulation of abnormal proteins and lipids that cannot be properly broken down. The accumulation of these substances ultimately leads to damage and degeneration of the nerve cells, resulting in a decline in neurological functions.
The disease is inherited as an autosomal recessive trait, meaning a dog must inherit two copies of the defective gene—one from each parent—to be affected. This genetic basis means that certain dog breeds may have a predisposition, including the Rottweiler, Chihuahua, and Collie, although the condition can occur in other breeds as well.
The exact cause at a molecular level is not yet fully understood; however, genetic defects that impair the normal function and breakdown of proteins and lipids in nerve cells play a central role. Studies suggest that mutations in specific genes responsible for protein homeostasis are linked to the disease.
Symptoms
Symptoms of neuroaxonal dystrophy in dogs usually appear at a young age, often within the first year of life. An initial sign of the disease can be an uncoordinated gait, known as ataxia. Affected dogs have difficulty coordinating their movements and may sway or fall.
As the disease progresses, further neurological symptoms may occur, including tremors, muscle twitching, and general weakness. These symptoms can vary in intensity but often lead to a significant impairment of quality of life.
Another common symptom is behavioral changes. Affected dogs may appear disoriented or show cognitive impairment. In advanced stages, the disease can also cause seizures and complete paralysis.
Diagnose
The diagnosis of neuroaxonal dystrophy is based on a combination of clinical symptoms, genetic testing, and, in some cases, histopathological examinations. A veterinarian will first assess the symptoms and perform a comprehensive neurological examination to rule out other neurological disorders.
Genetic tests are an important part of the diagnosis, especially in breeds predisposed to the disease. These tests can determine whether the dog is a carrier of the defective gene or is affected by the disease.
In some cases, a definitive diagnosis can only be made post-mortem through histopathological examinations of the brain, where the characteristic spheroid structures can be identified.
Therapie
Currently, there is no cure for neuroaxonal dystrophy in dogs. Treatment therefore focuses on alleviating symptoms and improving the quality of life of the affected dog. Physiotherapy and specialized training programs can help support motor functions and reduce muscle weakness.
In some cases, medications may be used to control seizures or to relieve pain and inflammatory conditions. However, the administration of such medications should always be done under veterinary supervision to avoid side effects.
Care and support from the owner are essential components of treatment. This includes providing a safe and comfortable environment as well as adapting daily activities to the dog’s needs and abilities.
Prognose und Nachsorge
The prognosis for dogs with neuroaxonal dystrophy is generally unfavorable, as the disease is progressive and there is no cure. The dog’s quality of life can be improved through the supportive measures described above; however, the disease typically progresses and ultimately leads to severe disabilities.
The life expectancy of affected dogs is often shortened, as the progressive neurological deterioration can lead to significant health complications. However, an early diagnosis and appropriate support can help maintain the dog’s well-being for as long as possible.
Prävention
Since neuroaxonal dystrophy is genetic, the most effective prevention strategy lies in responsible breeding practices. Genetic testing can identify carriers of the defective gene, allowing breeders to avoid pairings between carriers and thus reduce the spread of the disease.
Potential dog owners should inform themselves about the genetic risks of certain breeds and ensure that breeders perform tests for genetic diseases. This helps not only to prevent the spread of NAD but also to reduce the occurrence of other genetic disorders.
Awareness and education are also important steps for prevention. Veterinarians and breeders should be regularly informed about new research findings to develop and implement the most effective strategies for preventing genetic diseases in dogs.
Ausblick auf aktuelle Forschung
Neuroaxonal dystrophy (NAD) in dogs is a neurological disorder characterized by the degeneration of nerve cells in the brain. This disease is considered genetic, with certain breeds showing a higher predisposition. Research focuses on deciphering the genetic causes and mechanisms that contribute to the development of this disease. Scientists are working to identify specific gene mutations associated with NAD to better understand how the disease is inherited and develops at a cellular level.
A significant advance in research is the development of genetic tests that make it possible to identify carriers of the disease in breeding programs. These tests are particularly useful for breeders to minimize the risk of affected puppies being born. Future studies are focusing on exploring gene therapies that could potentially help slow or stop the effects of the disease by correcting the underlying genetic defects.
Another important aspect of research is the study of the pathophysiology of the disease. Scientists are investigating how the degeneration of nerve cells affects the behavior and motor skills of affected dogs. Animal models are used to study the disease in a controlled environment, leading to a better understanding of disease progression and the development of potential therapeutic approaches.
Furthermore, current studies are investigating how environmental factors or secondary genetic elements might influence the development and course of the disease. These investigations could lead to new insights into preventive measures that reduce the risk of NAD development in genetically susceptible dogs. Research is also striving to identify potential biomarkers that could enable early diagnosis and more effective management of the disease.
Research teams worldwide are working closely together to understand the impact of neuroaxonal dystrophy and develop new treatment methods. Collaboration between genetic researchers, veterinarians, and neurologists is crucial to finding comprehensive solutions. In the coming years, researchers hope to make significant progress that could substantially improve the lives of dogs with NAD.
Frequently Asked Questions (FAQs)
1. What is neuroaxonal dystrophy (NAD) in dogs?
2. Which dog breeds are most commonly affected by NAD?
3. What symptoms do dogs with NAD show?
4. How is NAD diagnosed in dogs?
5. Is there a cure for NAD in dogs?
6. Can environmental factors influence the risk of NAD?
7. How can I reduce the risk of NAD in my dog?
8. What research is currently being conducted on NAD?
9. Can diet or lifestyle influence the symptoms of NAD?
10. What should I do if I suspect my dog has NAD?
Literatur
- Cork, L. C., Troncoso, J. C., Price, D. L., Stanley, E. F., & Griffin, J. W. (1983). Canine neuroaxonal dystrophy. Journal of Neuropathology & Experimental Neurology, 42(3), 286–296. https://doi.org/10.1097/00005072-198305000-00008
- Hahn, K., Rohdin, C., Jagannathan, V., Wohlsein, P., Baumgärtner, W., Seehusen, F., Spitzbarth, I., Grandon, R., Drögemüller, C., & Jäderlund, K. H. (2015). TECPR2 associated neuroaxonal dystrophy in Spanish Water Dogs. PLOS ONE, 10(11), Article e0141824. https://doi.org/10.1371/journal.pone.0141824
- Tsuboi, M., Watanabe, M., Nibe, K., Yoshimi, N., Kato, A., Sakaguchi, M., Yamato, O., Tanaka, M., Kuwamura, M., & Kushida, K. (2017). Identification of the PLA2G6 c.1579G>A missense mutation in Papillon dog neuroaxonal dystrophy using whole exome sequencing analysis. PLOS ONE, 12(1), Article e0169002. https://doi.org/10.1371/journal.pone.0169002
- Lucot, K. L., Dickinson, P. J., Finno, C. J., Mansour, T. A., Letko, A., Minor, K. M., Mickelson, J. R., Drögemüller, C., Brown, C. T., & Bannasch, D. L. (2018). A missense mutation in the vacuolar protein sorting 11 (VPS11) gene is associated with neuroaxonal dystrophy in Rottweiler dogs. G3: Genes, Genomes, Genetics, 8(8), 2773–2780. https://doi.org/10.1534/g3.118.200376
- Nibe, K., Nakayama, H., & Uchida, K. (2009). Immunohistochemical features of dystrophic axons in Papillon dogs with neuroaxonal dystrophy. Veterinary Pathology, 46(3), 474–483. https://doi.org/10.1354/vp.08-VP-0156-U-FL
- Diaz, J. V., Duque, C., & Geisel, R. (2007). Neuroaxonal dystrophy in dogs: Case report in 2 litters of Papillon puppies. Journal of Veterinary Internal Medicine, 21(3), 531–534. https://doi.org/10.1111/j.1939-1676.2007.tb03002.x
- Cook, S. R., Schwarz, C., Guevar, J., Assenmacher, C.-A., Sheehy, M., Fanzone, N., Church, M. E., Murgiano, L., Casal, M. L., Jagannathan, V., Gutierrez-Quintana, R., Lowrie, M., Steffen, F., Leeb, T., & Ekenstedt, K. J. (2024). Canine RNF170 single base deletion in a naturally occurring model for human neuroaxonal dystrophy. Movement Disorders, 39(11), 2049–2057. https://doi.org/10.1002/mds.29977